Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Handbook of Experimental Pharmacology
|
November 8, 2019
Blinding and Randomization
Anton Bespalov, Karsten Wicke, Vincent Castagné
Expert Opinion on Investigational Drugs
|
November 10, 2015
Investigational drugs targeting 5-HT6 receptors for the treatment of Alzheimer's disease
Karsten Wicke, Andreas Haupt, Anton Bespalov
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
November 7, 2012
Dopamine D₃ receptor antagonism--still a therapeutic option for the treatment of schizophrenia
Gerhard Gross, Karsten Wicke, Karla U Drescher
European Journal of Pharmacology
|
February 5, 2013
Synthetic Aβ oligomers (Aβ(1-42) globulomer) modulate presynaptic calcium currents: prevention of Aβ-induced synaptic deficits by calcium channel blockers
David Hermann, Mario Mezler, Michaela K Müller, et al.
European Journal of Pharmacology
|
July 19, 2008
Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression
Anton Y Bespalov, Marcel M van Gaalen, Irina A Sukhotina, et al.
Combinatorial Chemistry & High Throughput Screening
|
December 12, 2012
Establishment of a secondary screening assay for P/Q-type calcium channel blockers
David Hermann, Mario Mezler, Andrew M Swensen, et al.
Journal of Pharmacological and Toxicological Methods
|
July 18, 2017
Measuring drug absorption improves interpretation of behavioral responses in a larval zebrafish locomotor assay for predicting seizure liability
Steven Cassar, Laura Breidenbach, Amanda Olson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 15, 2008
Inhibition of Calpain Prevents N-Methyl-D-aspartate-Induced Degeneration of the Nucleus Basalis and Associated Behavioral Dysfunction
Volker Nimmrich, Robert Szabo, Csaba Nyakas, et al.
Journal of Medicinal Chemistry
|
August 1, 2017
Discovery of Novel and Highly Selective Inhibitors of Calpain for the Treatment of Alzheimer's Disease: 2-(3-Phenyl-1H-pyrazol-1-yl)-nicotinamides
Andreas Kling, Katja Jantos, Helmut Mack, et al.
Nanoscale Advances
|
September 22, 2022
Trafficking of JC virus-like particles across the blood-brain barrier
Dong Ye, Tina Zimmermann, Victoria Demina, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Handbook of Experimental Pharmacology
|
November 8, 2019
Blinding and Randomization
Anton Bespalov, Karsten Wicke, Vincent Castagné
Expert Opinion on Investigational Drugs
|
November 10, 2015
Investigational drugs targeting 5-HT6 receptors for the treatment of Alzheimer's disease
Karsten Wicke, Andreas Haupt, Anton Bespalov
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
November 7, 2012
Dopamine D₃ receptor antagonism--still a therapeutic option for the treatment of schizophrenia
Gerhard Gross, Karsten Wicke, Karla U Drescher
European Journal of Pharmacology
|
February 5, 2013
Synthetic Aβ oligomers (Aβ(1-42) globulomer) modulate presynaptic calcium currents: prevention of Aβ-induced synaptic deficits by calcium channel blockers
David Hermann, Mario Mezler, Michaela K Müller, et al.
European Journal of Pharmacology
|
July 19, 2008
Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression
Anton Y Bespalov, Marcel M van Gaalen, Irina A Sukhotina, et al.
Combinatorial Chemistry & High Throughput Screening
|
December 12, 2012
Establishment of a secondary screening assay for P/Q-type calcium channel blockers
David Hermann, Mario Mezler, Andrew M Swensen, et al.
Journal of Pharmacological and Toxicological Methods
|
July 18, 2017
Measuring drug absorption improves interpretation of behavioral responses in a larval zebrafish locomotor assay for predicting seizure liability
Steven Cassar, Laura Breidenbach, Amanda Olson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 15, 2008
Inhibition of Calpain Prevents N-Methyl-D-aspartate-Induced Degeneration of the Nucleus Basalis and Associated Behavioral Dysfunction
Volker Nimmrich, Robert Szabo, Csaba Nyakas, et al.
Journal of Medicinal Chemistry
|
August 1, 2017
Discovery of Novel and Highly Selective Inhibitors of Calpain for the Treatment of Alzheimer's Disease: 2-(3-Phenyl-1H-pyrazol-1-yl)-nicotinamides
Andreas Kling, Katja Jantos, Helmut Mack, et al.
Nanoscale Advances
|
September 22, 2022
Trafficking of JC virus-like particles across the blood-brain barrier
Dong Ye, Tina Zimmermann, Victoria Demina, et al.
Page
of 2